NSC51349 selectively inhibits cutaneous HPV replication by targeting viral E2 activity, potentially paving the way for first HPV antivirals.

5529 Background: There is a rising incidence of HPV-related OP, which has a distinct prognosis. Previous studies in other viral-related cancers such as nasopharyngeal carcinoma have shown that the ...